RxDoctor Payments Data

Jonathan Hayward, PA

Physician Assistant · Marinette, WINPI 1851334395

Payments from drug & device makers

$2,115in general payments, 2019–2025

Across 114 payments — averaging $18.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$364
  • Lilly USA, LLC$263
  • Sun Pharmaceutical Industries Inc.$261
  • Johnson & Johnson$244
  • Galderma Laboratories, L.p.$219
  • Janssen Scientific Affairs, LLC$180
  • plus $585 from 8 others

What the payments were for

  • Food & beverage$2,115100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,115 in reported general payments places this provider in the 90th percentile of 2,804 physician assistant providers in Wisconsin.

See all physician assistant providers in Wisconsin

Medicare billing

Part B allowed, 2024
$85,947
Medicare patients
196
Services billed
1,479

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin150$46,217
EliquisApixaban135$40,338
Lagevrio (Eua)Molnupiravir23$22,729
ArexvyRsvpref3 Antigen/As01e/Pf47$14,534
RybelsusSemaglutide14$13,551
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen473$11,979
JanuviaSitagliptin Phosphate37$10,584
Gabapentin283$9,466
Pregabalin73$9,180
XareltoRivaroxaban28$7,451
Tramadol Hcl228$5,888
Ondansetron Hcl28$5,368
Atorvastatin Calcium115$5,324
GemtesaVibegron21$5,104
Bumetanide82$5,010

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$154$40,338135 claims
Johnson & JohnsonXarelto$244$7,45128 claims
Lilly USA, LLCOlanzapine$263$1,45413 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,804 physician assistant providers in Wisconsin.

Other physician assistant in Marinette

See the full list for Wisconsin

Where these figures come from

Is this you, or does something look wrong? →